![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Allergy Therapeutics' hail successful primary outcome of peanut allergy treatment (Proactive Investors) View |
![]() |
Allergy Therapeutics hails progression of peanut allergy vaccine (Proactive Investors) View |
![]() |
Allergy Therapeutics plc - Financial, Strategy u0026 operations update (Five Minute Pitch TV) View |
![]() |
Allergy Therapeutics Investor Update (Five Minute Pitch TV) View |
![]() |
Palforzia FAQ's With Dr. Karkhanis (AllergySA) View |
![]() |
Allergy Therapeutics' set for phase III trial after positive results from grass pollen immunotherapy (Proactive Investors) View |
![]() |
Allergy Therapeutics preparing the ground for big opportunities in the US (Proactive Investors) View |
![]() |
Allergy Therapeutics reveal record pre-Ru0026D operating profit with continued sales growth (Proactive Investors) View |
![]() |
Allergy Therapeutics boss says the firm is outperforming its competitors (Proactive Investors) View |
![]() |
Influence of antigen density and TLR ligands on preclinical efficacy of a VLP-based vaccine (Allergy) View |